Cooper Q1 2021 Earnings Report
Key Takeaways
CooperCompanies announced its Q1 2021 financial results, with revenue up 5% year-over-year to $680.5 million. GAAP diluted earnings per share were $42.31, and non-GAAP diluted earnings per share were $3.17, an 18% increase from the previous year. The company initiated fiscal year 2021 guidance, expressing enthusiasm for future prospects.
Revenue increased by 5% year-over-year, reaching $680.5 million.
CooperVision (CVI) revenue increased by 4% to $507.0 million.
CooperSurgical (CSI) revenue increased by 8% to $173.5 million.
Non-GAAP diluted earnings per share increased by 18% to $3.17.
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Forward Guidance
CooperCompanies provided fiscal year 2021 guidance, with total revenue expected to be between $2,800 and $2,845 million and non-GAAP diluted EPS between $12.90 and $13.10.
Positive Outlook
- Fiscal 2021 total revenue $2,800 - $2,845 million (12% to 14% constant currency)
- CVI revenue $2,090 - $2,120 million (9% to 11% constant currency)
- CSI revenue $710 - $725 million (19% to 22% constant currency)
- Fiscal 2021 non-GAAP diluted EPS $12.90 - $13.10
- Company is enthusiastic about prospects for the remainder of the year, and into the future.
Challenges Ahead
- Resurgences of COVID-19 are viewed as a significant risk factor to the outlook.
- Guidance excludes amortization and impairment of intangible assets.
- Guidance excludes acquisition, integration and manufacturing related costs.
- The company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses.
- Unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share.
Revenue & Expenses
Visualization of income flow from segment revenue to net income